RecruitingNCT06371404

Imaging Traumatic Stress and Alcohol Use Disorder With [18F]Bavarostat


Sponsor

Yale University

Enrollment

150 participants

Start Date

Jun 5, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The overall objective of this study it to use Positron Emission Tomography (PET) brain imaging and a radiotracer that measures the epigenetic marker Histone Deacetylase 6 (HDAC6) to examine HDAC6 expression in people with Post-Traumatic Stress Disorder (PTSD), Alcohol Use Disorder (AUD), or concurrent PTSD and AUD with control groups. While there are a large number of studies conducted in preclinical stress and addiction models, these findings have not been translated to people living with these disorders. This study will examine relationships between HDAC6 and clinical variables of interest. Findings could direct treatment development.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This study uses a new brain imaging tracer called [18F]Bavarostat to examine how PTSD (post-traumatic stress disorder) and alcohol use disorder affect specific chemical pathways in the brain. The goal is to better understand the brain biology behind trauma and addiction. **You may be eligible if...** - You are between 18 and 70 years old - You have a current diagnosis of PTSD (based on DSM-5 criteria), OR a diagnosis of alcohol use disorder, OR you have experienced a traumatic event but don't have PTSD (as a comparison group) - You are in generally good health **You may NOT be eligible if...** - You have a serious current medical condition - You have other significant psychiatric diagnoses that would interfere - You are pregnant or breastfeeding - You are unable to undergo brain imaging (e.g., metal implants) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGBavarostat

Up to two injections of ≤ 5 mCi \[F18\] Bavarostat


Locations(1)

Yale University

New Haven, Connecticut, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06371404


Related Trials